Evaluation of 47 soft tissue sarcoma resection specimens after isolated limb perfusion with TNF-α and melphalan: Histologically characterized improved margins correlate with absence of recurrences

Annals of Surgical Oncology

Volumn 16, Issue 3, 2009, Pages 676-686

  Grabellus, Florian ^a   Kraft, Corinna ^a   Sheu, Sien Yi ^a   Ebeling, Peter ^a   Bauer, Sebastian ^a   Lendemans, Sven ^a   Schmid, Kurt W ^a   Taeger, Georg ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIMB PERFUSION; LIMB SALVAGE; MALE; SOFT TISSUE SARCOMA; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LIMB SALVAGE; MALE; MELPHALAN; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SARCOMA; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 60449116629     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0277-4     Document Type: Article

References (45)

1. Nascimento AG. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002.
2. PH Nijhuis M Schaapveld R Otter 1999 Epidemiological aspects of soft tissue sarcomas (STS)-consequences for the design of clinical STS trials Eur J Cancer 35 1705 1710
3. JN Cormier RE Pollock 2004 Soft tissue sarcomas CA Cancer J Clin 54 94 109
4. IC Dickinson DJ Whitwell D Battistuta 2006 Surgical margin and its influence on survival in soft tissue sarcoma ANZ J Surg 76 104 109
5. MD McKee DF Liu JJ Brooks 2004 The prognostic significance of margin width for extremity and trunk sarcoma J Surg Oncol 85 68 76
6. AT Stotter RP A'Hern C Fisher 1990 The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival Cancer 65 1119 1129
7. CS Trovik HC Bauer TA Alvegard 2000 Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register Eur J Cancer 36 710 716
8. WF Enneking SS Spanier MM Malawer 1981 The effect of the Anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh Cancer 47 1005 1022
9. CH Gerrand JS Wunder RA Kandel 2001 Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence J Bone Joint Surg Br 83 1149 1155
10. N Kawaguchi AR Ahmed S Matsumoto 2004 The concept of curative margin in surgery for bone and soft tissue sarcoma Clin Orthop Relat Res 419 165 72
11. M Sampo M Tarkkanen R Huuhtanen 2008 Impact of the smallest surgical margin on local control in soft tissue sarcoma Br J Surg 95 237 243
12. WW Virkus D Marshall WF Enneking 2002 The effect of contaminated surgical margins revisited Clin Orthop Relat Res 397 89 94
13. SH Herbert BW Corn LJ Solin 1993 Limb-preserving treatment for soft tissue sarcomas of the extremities. The significance of surgical margins Cancer 72 1230 1238
14. JJ Lewis D Leung M Heslin 1997 Association of local recurrence with subsequent survival in extremity soft tissue sarcoma J Clin Oncol 15 646 652
15. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980;153(Nov-Dec):106-120.
16. PF Choong 2006 Surgical margins for soft tissue sarcoma: size does matter ANZ J Surg 76 97
17. YB Kim KH Shin J Seong 2008 Clinical significance of margin status in postoperative radiotherapy for extremity and truncal soft-tissue sarcoma Int J Radiat Oncol Biol Phys 70 139 144
18. WC Williard SI Hajdu ES Casper 1992 Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity Ann Surg 215 269 275
19. P Hohenberger WM Wysocki 2008 Neoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose? Oncologist 13 175 186
20. PW Pisters LB Harrison DH Leung 1996 Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma J Clin Oncol 14 859 868
21. PW Pisters 2006 Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: home run, base hit, or strike out? J Clin Oncol 24 549 551
22. Pisters PW. Treatment of localized soft-tissue sarcoma: lessons learned. Oncology (Williston Park). 2007;21:731-2, 735.
23. JC Yang AE Chang AR Baker 1998 Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity J Clin Oncol 16 197 203
24. G Taeger F Grabellus LE Podleska 2008 Effectiveness of regional chemotherapy with TNF-alpha/melphalan in advanced soft tissue sarcoma of the extremities Int J Hyperthermia 24 193 203
25. AM Eggermont KH Schraffordt JM Klausner 1996 Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience Ann Surg 224 756 764
26. DJ Grunhagen JH de Wilt WJ Graveland 2006 Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma Cancer 106 1776 1784
27. S Bonvalot A Laplanche F Lejeune 2005 Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better? Ann Oncol 16 1061 1068
28. FJ Lejeune N Pujol D Lienard 2000 Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities Eur J Surg Oncol 26 669 678
29. Nachmany I, Subhi A, Meller I, et al. Efficacy of high vs low dose TNF-isolated limb perfusion for locally advanced soft tissue sarcoma. Eur J Surg Oncol. 2008 (Epub ahead of print).
30. J Issakov O Merimsky M Gutman 2000 Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations Ann Surg Oncol 7 155 159
31. CC Jaffe 2006 Measures of response: RECIST, WHO, and new alternatives J Clin Oncol 24 3245 3251
32. DJ Grunhagen JH de Wilt WJ Graveland 2006 The palliative value of tumor necrosis factor alpha-based isolated limb perfusion in patients with metastatic sarcoma and melanoma Cancer 106 156 162
33. Coindre JM, Terrier P, Bui NB, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol. 1996;14:869-77.
34. PW Pisters DH Leung J Woodruff 1996 Analysis of prognostic factors in 1, 041 patients with localized soft tissue sarcomas of the extremities J Clin Oncol 14 1679 1689
35. A Stojadinovic DH Leung P Allen 2002 Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables J Clin Oncol 20 4344 4352
36. RS Bell B O'Sullivan FF Liu 1989 The surgical margin in soft-tissue sarcoma J Bone Joint Surg Am 71 370 375
37. AJ Hayes SJ Neuhaus MA Clark 2007 Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma Ann Surg Oncol 14 230 238
38. MS Kim SY Lee WH Cho 2008 Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients Ann Surg Oncol 15 906 914
39. A Alho TA Alvegard O Berlin 1989 Surgical margin in soft tissue sarcoma. The Scandinavian Sarcoma Group experience Acta Orthop Scand 60 687 692
40. RJ van Ginkel KM Thijssens E Pras 2007 Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: three time periods at risk for amputation Ann Surg Oncol 14 1499 506
41. EM Noorda BC Vrouenraets OE Nieweg 2003 Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities Cancer 98 1483 1490
42. E Pennacchioli M Deraco L Mariani 2007 Advanced extremity soft tissue sarcoma: prognostic effect of isolated limb perfusion in a series of 88 patients treated at a single institution Ann Surg Oncol 14 553 559
43. TF DeLaney IJ Spiro HD Suit 2003 Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas Int J Radiat Oncol Biol Phys 56 1117 1127
44. KG Billingsley JJ Lewis DH Leung 1999 Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma Cancer 85 389 395
45. KK Tanabe RE Pollock LM Ellis 1994 Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas Cancer 73 1652 1659